Company Search:
Advanced Search
Sponsored Links
Unicocell Biomed Co Ltd Company Snapshot
Unicocell Biomed Co Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Unicocell Biomed Co Ltd with three other companies in this sector in Taiwan: PharmaEngine Inc (2016 sales of 1.13 billion Taiwanese Dollars [US$38.66 million] ), Sofiva Genomics Co Ltd (383.95 million Taiwanese Dollars [US$13.08 million] ), and Medigen Biotechnology Corporation (399.89 million Taiwanese Dollars [US$13.62 million] of which 81% was Drug Discovery).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Unicocell Biomed Co Ltd
  Stock Performance Chart for Unicocell Biomed Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 93.49
(Figures in Taiwanese Dollars)
1 Week 5.7%   13 Weeks 11.7%  
4 Weeks 14.0%   52 Weeks -34.9%  
Unicocell Biomed Co Ltd Key Data:
  Ticker: 6539 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 1,002,960,000
(Year Ending Jan 2017).
Employees: N/A
  Currency: Taiwanese Dollars Market Cap: 3,982,913,334
  Fiscal Yr Ends: December Shares Outstanding: 42,602,560
  Share Type: Gu Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.